Medical Center Pharmacy Recalls C-Albumin Eye Drops Due to Sterility Concerns
Medical Center Pharmacy is recalling specific lots of C-Albumin Eye Drop 10% S because production processes cannot assure sterility. Patients in Tennessee who received these prescriptions should contact their healthcare provider.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, which corresponds to a Severe severity score (4) according to the rubric, as it involves a product where use may cause temporary or medically reversible adverse health consequences.
Plain-English summary
Medical Center Pharmacy, Inc. is recalling C-Albumin Eye Drop 10% S, packaged in 10 mL bottles. The recall involves two specific lots identified by the codes 03042020@28 (Best Use Date: 03/18/2020) and 03032020@3 (Best Use Date: 03/17/2020). The product is prescription-only and was distributed to specific patients in Tennessee.
The recall was initiated due to a lack of assurance of sterility. The firm identified concerns with production processes that cannot guarantee the sterility of products intended to be sterile. This classification is designated as FDA Class II.
Patients who have received prescriptions for these specific lots of C-Albumin Eye Drop 10% S should contact their healthcare provider or pharmacist for further instructions. The recall is limited to the specific lots and distribution area mentioned above.
The recalled product
- Product
- C-*Albumin Eye Drop 10% S, packaged in 10 mL bottles, Rx only, Medical Center Pharmacy, 2401 Ocoee Street, Cleveland, TN 37311, NDC 44206-0251-05.
- Manufacturer
- Medical Center Pharmacy, Inc.
- Category
- Drug — Ophthalmic
- Hazard
- Affected units
- 2
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot: 03042020@28 BUD: 03/18/2020
- 03032020@3 BUD: 03/17/2020
Distribution
Distributed in 1 state:
Part of a larger recall action
This product is one of 5 recalled by Medical Center Pharmacy, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 5 products in this recall →Related recalls
Same manufacturer · Medical Center Pharmacy, Inc.
See all →- SevereMedical Center Pharmacy Recalls Mitomycin Eye Drops Due to Sterility Concerns
FDA (Drugs) · 2020-04-08
- SevereMorphine 2 mg/mL CADD Cassettes Recalled for Sterility Concerns
FDA (Drugs) · 2020-04-08
- SevereMedical Center Pharmacy Recalls Vancomycin Opthal Drops Due to Sterility Concerns
FDA (Drugs) · 2020-04-08
- SevereMedical Center Pharmacy Recalls Gentamicin Bladder Irrigation Bags
FDA (Drugs) · 2020-04-08
Same hazard · sterility failure
See all →- SevereAvKare Carboxymethylcellulose Sodium Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereAvKare Carboxymethylcellulose Sodium Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereROHTO DIGI-EYE Eye Drops Recalled Over Sterility Assurance Gap
FDA (Drugs) · 2026-07-29
- HighROHTO DRY-AID Eye Drops Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- SevereOne-Piece Introducer Tray kits recalled for sterility failure
FDA (Devices) · 2026-07-22
Similar recalls
- HighAcetylcysteine eye drops recalled for sterility assurance defect
FDA (Drugs) · 2022-11-09
- SevereAcetylcysteine Eye Drops Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2019-04-24
- SevereColonia Care Pharmacy Recalls C-Albumin 5% Ophthalmic Solution
FDA (Drugs) · 2019-10-09
- SevereEssential Wellness Pharma Recalls Acetylcysteine Eye Drops Due to Sterility Concerns
FDA (Drugs) · 2015-11-25
- SevereFDA Recalls Atropine Eye Drops Due to Sterility Concerns
FDA (Drugs) · 2019-04-24
- SevereAnderson Compounding Pharmacy Recalls Amphotericin B Eye Drops for Sterility Concerns
FDA (Drugs) · 2019-04-24